Wuhan Keqian Biology Co.,Ltd (SHA:688526)
China flag China · Delayed Price · Currency is CNY
12.68
-0.29 (-2.24%)
Sep 2, 2026, 3:00 PM CST

SHA:688526 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
826.58935.65933.041,027974.141,083
Other Revenue
9.714.098.8837.1427.1219.86
836.28949.74941.921,0641,0011,103
Revenue Growth
-18.71%0.83%-11.48%6.27%-9.22%30.81%
Cost of Revenue
320.38330.72360.45321.43279.05230.42
Gross Profit
515.9619.03581.48742.65722.22872.6
Selling, General & Admin
151.3160.28169.4213.2219.26201.91
Research & Development
110.3696.4186.1288.51102.7580
Other Operating Expenses
-6.061.28-0.93-0.826.295.92
Operating Expenses
246.52247.8266.47385.36339.01296.9
Operating Income
269.37371.23315.01357.29383.21575.71
Interest Expense
---4.77-8.16-5.45-1.81
Interest & Investment Income
33.5163.8373.1794.1275.6971.86
Currency Exchange Gain (Loss)
-0.89-0.8900.05--
Other Non Operating Income (Expenses)
15.851.15-0.72-0.21-0.2-0.27
EBT Excluding Unusual Items
317.85435.31382.69443.1453.25645.48
Impairment of Goodwill
---3.31---
Gain (Loss) on Sale of Investments
38.3433.2730.99-10.191.44-
Gain (Loss) on Sale of Assets
-0.06-0.93---
Asset Writedown
-10.31-1.28-0.86-1.72-0.14-1.57
Legal Settlements
-----0.82
Other Unusual Items
10.8814.2427.726.3912.0615.32
Pretax Income
356.7481.54438.13457.58466.61660.05
Income Tax Expense
44.3264.656.646257.4689.41
Earnings From Continuing Operations
312.39416.94381.49395.58409.15570.64
Minority Interest in Earnings
2.161.780.860.350.370.11
Net Income
314.55418.72382.35395.93409.52570.74
Net Income to Common
314.55418.72382.35395.93409.52570.74
Net Income Growth
-30.04%9.51%-3.43%-3.32%-28.25%27.45%
Shares Outstanding (Basic)
463465466466465464
Shares Outstanding (Diluted)
463465466466465464
Shares Change
-1.33%-0.22%0.10%0.10%0.29%20.20%
EPS (Basic)
0.680.900.820.850.881.23
EPS (Diluted)
0.680.900.820.850.881.23
EPS Growth
-29.10%9.76%-3.53%-3.41%-28.46%6.03%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
281.88344.66285.74433.53320.86156.82
Free Cash Flow Per Share
0.610.740.610.930.690.34
Dividend Per Share
0.6400.6400.4300.4300.1900.190
Dividend Growth
48.84%48.84%0%126.32%0%-34.48%
Gross Margin
61.69%65.18%61.73%69.79%72.13%79.11%
Operating Margin
32.21%39.09%33.44%33.58%38.27%52.19%
Profit Margin
37.61%44.09%40.59%37.21%40.90%51.74%
Free Cash Flow Margin
33.71%36.29%30.34%40.74%32.05%14.22%
EBITDA
387.59482.99423.23470.54480.16638.35
EBITDA Margin
46.35%50.85%44.93%44.22%47.95%57.87%
D&A For EBITDA
118.22111.76108.22113.2496.9562.64
EBIT
269.37371.23315.01357.29383.21575.71
EBIT Margin
32.21%39.09%33.44%33.58%38.27%52.19%
Effective Tax Rate
12.42%13.41%12.93%13.55%12.31%13.55%
Revenue as Reported
462.45949.74941.921,0641,0011,103
Advertising Expenses
-25.4625.734.12.872.96